Treatment of Complex Regional Pain Syndrome
Complex regional pain syndrome requires immediate initiation of physical therapy and rehabilitation as the cornerstone of treatment, combined with a multimodal pharmacologic approach that includes bisphosphonates for inflammatory features, neuropathic pain medications (gabapentin, tricyclic antidepressants, SNRIs), and consideration of sympathetic blocks for vasomotor symptoms, with spinal cord stimulation reserved for refractory cases.
Treatment Algorithm
First-Line: Immediate Rehabilitation (Start Within Days of Diagnosis)
- Progressive tactile desensitization to address hyperalgesia/allodynia
- Normalization of movement to prevent range-of-motion loss and motor dysfunction
- Edema management techniques
- Physical therapy should begin immediately—pain severity should NOT delay rehabilitation 1
Concurrent Pharmacologic Management by Subtype
For Inflammatory Subtype:
- Bisphosphonates are the only treatment with uniformly positive evidence across multiple trials 2, 3
- Consider corticosteroids in early-stage CRPS 1
For Neuropathic/Nociplastic Features:
- Anticonvulsants (gabapentin, pregabalin—α-2-δ calcium-channel antagonists) 4
- Tricyclic antidepressants (amitriptyline, nortriptyline) 4
- SNRIs (duloxetine, venlafaxine) 4
- Ketamine for severe neuropathic component 2, 1
For Vasomotor Disturbances:
Adjunctive Medications:
- Topical agents (lidocaine, capsaicin, ketamine) for peripheral symptoms 4
- NSAIDs may be used but evidence is limited 1
- Extended-release opioids may be considered as part of multimodal strategy for neuropathic pain, but monitor closely 4
Psychological Support (Integrate Early)
- Cognitive behavioral therapy, biofeedback, relaxation training provide pain relief for chronic pain conditions 4
- Graded motor imagery/mirror therapy shows improvement in CRPS 3
Interventional Procedures (When Conservative Treatment Fails)
Indications for referral to pain specialist:
- Pain severity prevents participation in rehabilitation 1
- Inadequate response to 3-6 months of comprehensive conservative management
Options include:
- Spinal cord stimulation: Most evidence-based interventional option for refractory CRPS, though effect sizes may be modest 5, 2, 1, 3
- Dorsal root ganglion stimulation: Alternative neuromodulation approach 6
- Intrathecal baclofen: Specifically for end-stage motor disturbances 2
Critical Pitfalls to Avoid
Delayed Treatment: Early aggressive management is critical—long-term outcomes deteriorate significantly when treatment is delayed 1, 6. Do not wait for "definitive" diagnosis if Budapest Criteria are met.
Prolonged Immobilization: Avoid unnecessary immobilization, which worsens outcomes 6. Pain should not be an excuse to delay mobilization.
Premature Diagnosis: Ensure alternative diagnoses (infection, fracture, DVT, peripheral nerve injury) are excluded before labeling as CRPS 1, 6.
Monotherapy Approach: CRPS requires multimodal treatment targeting different pathophysiologic mechanisms simultaneously 4, 2.
Medication-Only Strategy: Pharmacotherapy should facilitate rehabilitation participation, not replace it 6. Function restoration is the primary therapeutic objective.
Evidence Quality Considerations
The strongest evidence supports bisphosphonates and physical therapy 3. No FDA-approved medications exist specifically for CRPS 1. Most pharmacologic recommendations are extrapolated from neuropathic pain guidelines 4. Interventional procedures have limited high-quality randomized controlled trial data, with spinal cord stimulation showing the most consistent (though modest) benefit 5, 3.
Monitor all long-term pharmacologic therapy for side effects, adverse effects, and compliance before initiating treatment 4.